Home Analyst Ratings Cree Stock Gets a Downgrade from JP Morgan. It's Now Neutral

Cree Stock Gets a Downgrade from JP Morgan. It’s Now Neutral

JP Morgan took its Cree [CREE] rating to the equivalent of Neutral, and the price target to 108.0, in a ‎research note dated 2021-01-05. That figure represents around a 0.94% premium from where the ‎company’s shares closed on Monday. Other analysts also revised their coverage, with JP Morgan’s ‎analysts upgrading the shares from “a Neutral” rating to “an Overweight” rating in a research note to ‎investors issued in mid November. Meanwhile, JP Morgan had raised its rating on CREE to “an ‎Overweight” from the earlier “Neutral”, in a research note produced for clients November 19, 2020. In ‎addition, there was a downgrade from ROTH Capital on August 19, 2020. The rater changed CREE from ‎‎”a Buy” to “a Neutral”.

Get the hottest stocks to trade every day before the ‎market opens 100% free. Click here now. 

Is Cree Inc. [NASDAQ:CREE] a ‎Good Buy Right Now?

It should be noted that CREE technical indicators for short, intermediate as ‎well as long term progress have placed an overall average of 100% as Buy. The average signal changed ‎from 100% Buy in the last week and compares with 100% Buy in the past month. Data from Cree Inc.’s ‎Trend Spotter indicated that the signals were Weakening. The stock current average is 1.88 million ‎shares in the past 20 days and the short term average signal indicates a 100% Buy. In the last 50 days, ‎the average trading volume was 1.6 million shares while the medium term average advocated for 100% ‎Buy. The average long-term signal stands at 100% Buy and the 100-day average volume stands at 1.38 ‎million shares.


The 2021 Backdoor Crypto Portfolio (free)

Even if you’re not actively in crypto, you deserve to know what’s actually going on...

Because while leading assets such as Bitcoin (BTC) and Ethereum (ETH) are climbing in value, a select group of public “crypto stocks” are surging right along with them. More importantly, these stocks are outpacing the returns these leading crypto assets aren already producing.

Click here to get the full story… along with our long list of backdoor Bitcoin strategies. It’s free.

Sponsored


CREE Price Performance

On Wall Street, Cree Inc. [NASDAQ:CREE] finished ‎Monday’s session up 1.03% at $106.99. The stock went up to $116.49 at the same session while its ‎lowest single day price was $105.72. In the last five days, it saw a rise of about 3.77%, Cree Inc. shares ‎gained by almost 1.03% since the beginning of the year. However, the share price has dropped to as ‎low as -2.00% below its one year high. On 01/04/21, the company shares recorded $116.49, the highest ‎single-day price it has got to in the last 52-weeks and a 52-week low was seen on 01/04/21, the same ‎year at $105.72. The company’s shares have inclined by 134.68% in the past year. The 50-day SMA ‎achieved is $84.09 while the 200-day SMA is $63.59. Volume gained to 2.72 million from 1.54 million in ‎the previous session.

CREE Stock Support And Resistance Levels

On the 24-hour scale, the ‎immediate backing is perceived around 102.98 level, and in case of violation of this particular level, it ‎will cause more drop to 98.96 level. On the upper level, 120.50 is still the key resistance. The stock may ‎increase to the subsequent resistance at 113.75. The Relative Strength Index (RSI) pinned on the 14-‎day chart is 68.15, implying a neutral technical stance while the MACD stands at 6.22, meaning price will ‎increase in the next trading period. Percent R indicator moved to 36.19%, implying low price ‎movement. Stochastic %K at 76.42% suggest selling the stock.

What is the short interest in Cree ‎Inc.?

Short interest in the Cree Inc. stock has plunged, decreasing by -1.03 million shares to total ‎‎13.5 million shares on Dec 14, 2020. The interest had seen shares on Nov 12, 2020 stand at 12.47 million, ‎data from Yahoo Finance shows. The increase of 7.63% suggests the stock saw some increased bearish ‎sentiment. The stock’s days to cover (short ratio) moved to while the shorted shares account for just ‎‎13.86% of the overall float for the stock.

Cree Inc.’s Biggest Shareholders: Who Owns Cree Inc. ‎‎[CREE]?

Filings by Capital Research & Management Co showed that the firm now holds a total of ‎‎13,435,964 shares or roughly 12.18% of the outstanding CREE shares. This means their shares have ‎increased by 330,746 from the 13,435,964 the investor reportedly held in its prior 13-F filing. With the ‎conclusion of the purchase, The Vanguard Group, Inc. updated stake is worth $881,698,047. Details in ‎the latest 13F filings reveal that BlackRock Fund Advisors disposed off their -2.23% stake valued at ‎‎$786,420,027 while ClearBridge Investments LLC cut theirs at $756,510,247. During the last quarter, ‎BlackRock Fund Advisors liquidated -198,221 of its shares in Cree Inc. while ClearBridge Investments ‎LLC sold -340,721 shares. The PRIMECAP Management Co.’s holdings currently number 6,047,489 ‎shares at $647020848.11. According to the firm’s last 13F report, Capital Research & Management Co ‎shares in the company at filing stood at 5,646,653 shares, roughly $510,400,965.

CREE Earnings ‎Forecast For The Current Quarter

Cree Inc. [CREE] is expected to report weak earnings results for ‎the quarter ending on Dec 2020. Consensus estimates give the company expected revenues of ‎‎$121.6M and an earnings per share of -$0.25 for Dec 2020. Looking further ahead, the company is ‎expected to report revenue of $128.54M at an EPS of -$0.2 for Mar 2021. The estimates represent ‎downside of 10.30% and 61.50% in the company’s revenue and earnings per share, respectively, on a ‎year-on-year basis.

Get the hottest stocks to trade every day before the ‎market opens 100% free. Click here now. 

CREE Earnings Estimates For ‎The Current Year

For the financial year, Cree Inc. [NASDAQ:CREE] is expected to bring in revenue ‎of $633.92M. The returns are nearly $-269.98 million lower than the company’s actual revenue ‎recorded in the fiscal year 2020. In terms of EPS for the 2021, estimate put it at -0.78, lower than that of ‎FY20 by -$0.33. Estimates put this year’s earnings growth at -73.30%, 61.50% for the next, and at an ‎annual -20.64% over the next 5-year period. As for sales, forecasts are for a decrease of -29.90% in the ‎current fiscal year and a further 10.30% over the following year.‎

Get The Best Stocks To Trade Every Day!

Join now to get the NewsHeater.com pre-market morning brief 100% free

Must Read

What Has Been Raising The Soleno (SLNO) Stock Up Before Market Open?

In recent premarket trading, Soleno Therapeutics Inc. (SLNO) has soared 3.77% at $1.10 per share. The Soleno stock closed at $1.06 yesterday, down -6.19%. Get...

Stealth BioTherapeutics Corp (MITO) Stock Going Down in PreMarket, Here’s What You Should Know

Stealth BioTherapeutics Corp (MITO) stock prices were up by a colossal 35% as of the market closing on May 6th, 2021, bringing the price...

Why Ocugen, Inc. (OCGN) stock is popping high today?

Shares of Ocugen, Inc. (OCGN) stock were popping high today on May 7, 2021, ahead of today’s earnings report.OCGN stock price saw a surge...

What Is Driving The Powerbridge (PBTS) Stock Higher In Premarket session?

At the last check, Powerbridge Technologies Co. Ltd. (NASDAQ: PBTS) shares were rising 10.71% to trade at $1.55 in premarket trades. The Powerbridge stock...

Beyond Meat, Inc. (BYND) Stock Trending Down After Management’s Uncertainty Over Fiscal Year Guidelines

Beyond Meat, Inc. (BYND) stock prices were down by 2.08% as of the market closing on May 6th, 2021, bringing the price per share...

Regional Health Properties, Inc. (RHE) Stock Skyrockets Following Trading of Exponential Volume of Shares

Regional Health Properties, Inc. (RHE) stock prices soared by 31.4% during early market hours on May 7th 2021, bringing the price per share up...

Orphazyme A/S (ORPH) Stock Plummeting After Failure of ORAIALS-01 Trial Announced

Orphazyme A/S (ORPH) stock prices plummeted by 27.77%  after the market opened on May 7th, 2021, bringing the price per share tumbling down to...

Avalon Holdings Corporation (NYSE:AWX) stock surged in the current trading session; here’s why

At last check, in the current trading session, AWX stock surged by 22.58% to $5.08. AWX stock previously closed the session at $4.14. The...

Related News

Ocugen Inc. (NASDAQ:OCGN) stock plunged in the premarket trading session; here’s why

At last check Ocugen Inc. (OCGN) stock had plunged by-11.92% to $9.61 in premarket trading session. OCGN stock previously closed at $10.91 losing -12.79%....

KeyBanc reiterates Magna International [MGA] rating to Overweight and sets new price target at $86

KeyBanc maintained its Magna International rating to the equivalent of Overweight but changed the price target to $86.0 from $72, in a research...

Jefferies upgrades Medifast [MED] to Buy rating with a $265 price target

Jefferies took its Medifast rating to the equivalent of Buy from Hold, and the price target to $265.0 from $205, in a research...

American Eagle Outfitters [AEO] Upgraded to Outperform at RBC Capital

RBC Capital took its American Eagle Outfitters rating to the equivalent of Outperform from Sector Perform, and the price target to $30.0 from...

KeyBanc reiterates Nike [NKE] rating to Overweight and sets new price target at $180

KeyBanc maintained its Nike rating to the equivalent of Overweight but changed the price target to $180.0 from $174, in a research note...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Get The Best Stocks To Trade Every Day!

Join now to get the NewsHeater.com pre-market morning brief 100% free

Get Best Morning Financial Newsletter... 100% Free

Best stocks ideas

Analysts’ Upgrades & Downgrades

Insider Watchlist

Important Earnings

We do not sell or share your information with anyone.

Get The Best Stocks To Trade Every Day!...100% Free

We do not sell or share your information with anyone.

Get The Best Stocks To Trade Every Day!

Join now to get the NewsHeater.com pre-market morning brief 100% free

We do not sell or share your information with anyone.